Pharmacy Department, Princess Alexandra Hospital, The Centre for Liver Disease Research, Translational Research Institute, The University of Queensland, Woolloongabba, Queensland 4102, Australia.
Cancer and Chronic Disease Research Group, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia.
World J Gastroenterol. 2017 Oct 28;23(40):7321-7331. doi: 10.3748/wjg.v23.i40.7321.
To investigate the impact of medication beliefs, illness perceptions and quality of life on medication adherence in people with decompensated cirrhosis.
One hundred adults with decompensated cirrhosis completed a structured questionnaire when they attended for routine outpatient hepatology review. Measures of self-reported medication adherence (Morisky Medication Adherence Scale), beliefs surrounding medications (Beliefs about Medicines Questionnaire), perceptions of illness and medicines (Brief Illness Perception Questionnaire), and quality of life (Chronic Liver Disease Questionnaire) were examined. Clinical data were obtained patient history and review of medical records. Least absolute shrinkage and selection operator and stepwise backwards regression techniques were used to construct the multivariable logistic regression model. Statistical significance was set at alpha = 0.05.
Medication adherence was "High" in 42% of participants, "Medium" in 37%, and "Low" in 21%. Compared to patients with "High" adherence, those with "Medium" or "Low" adherence were more likely to report difficulty affording their medications ( < 0.001), lower perception of treatment helpfulness ( = 0.003) and stronger medication concerns relative to medication necessity beliefs ( = 0.003). People with "Low" adherence also experienced greater symptom burden and poorer quality of life, including more frequent abdominal pain ( = 0.023), shortness of breath ( = 0.030), and emotional disturbances ( = 0.050). Multivariable analysis identified having stronger medication concerns relative to necessity beliefs (Necessity-Concerns Differential ≤ 5, OR = 3.66, 95%CI: 1.18-11.40) and more frequent shortness of breath (shortness of breath score ≤ 3, OR = 3.87, 95%CI: 1.22-12.25) as independent predictors of "Low"adherence.
The association between "Low" adherence and patients having strong concerns or doubting the necessity or helpfulness of their medications should be explored further given the clinical relevance.
探讨药物信念、疾病认知和生活质量对失代偿期肝硬化患者药物依从性的影响。
100 名失代偿期肝硬化患者在接受常规门诊肝病复查时,完成了一份结构化问卷。评估了自我报告的药物依从性(Morisky 药物依从性量表)、药物信念(药物信念问卷)、疾病和药物认知(简短疾病认知问卷)以及生活质量(慢性肝病问卷)。临床数据通过病史和病历回顾获得。采用最小绝对收缩和选择算子和逐步向后回归技术构建多变量逻辑回归模型。统计学意义设为α=0.05。
42%的参与者药物依从性为“高”,37%为“中”,21%为“低”。与药物依从性“高”的患者相比,药物依从性“中”或“低”的患者更有可能报告难以负担药物费用(<0.001)、治疗效果认知度较低(=0.003)和药物关注相对药物必要性信念更强(=0.003)。药物依从性“低”的患者还经历了更大的症状负担和更差的生活质量,包括更频繁的腹痛(=0.023)、呼吸急促(=0.030)和情绪障碍(=0.050)。多变量分析确定,药物关注相对必要性信念更强(必要性-关注差异≤5,OR=3.66,95%CI:1.18-11.40)和呼吸急促更频繁(呼吸急促评分≤3,OR=3.87,95%CI:1.22-12.25)是“低”依从的独立预测因子。
鉴于临床相关性,应进一步探讨“低”依从与患者对药物的强烈关注或怀疑药物的必要性或疗效之间的关系。